Episode Details
Back to EpisodesMonologue: Probable CTE - What We Know, What We Don't and Why the Words Matter
Description
This episode unpacks what "probable CTE" actually means — where the term comes from, what the science can and can't currently tell us, and why a single case (former Socceroos captain Paul Wade) has reignited debate about diagnosing a disease that's only ever been confirmed after death. It walks through the genuine case for and against using this label in living patients, and why the language we use around it matters.
Note: This episode is for educational purposes only and is not medical advice or a diagnostic tool. While I've done my best to accurately interpret the cited journal articles, please read the original sources yourself for full context before drawing conclusions.
06:00 - Segment One: What Chronic Traumatic Encephalopathy Actually Is
09:45 - Segment Two: Why You Can't Diagnose It in the Living — Yet
12:00 - Segment Three: "Probable CTE" — Where the Term Actually Comes From
17:09 - Segment Four: Why This Topic Divides Even the Experts — The Dose-Response Problem
21:30 - Segment Five: The Case For Diagnosing Probable CTE in Living Patients
24:00 - Segment Six: The Case Against — Or At Least, the Case for Caution
29:27 - Segment Seven: Why the Words We Use Actually Matter
32:50 - Segment Eight: Where This Leaves Us
Episode — Reference List
1. Martland, H.S. Punch drunk. Journal of the American Medical Association. 1928;91(15):1103–1107.
2. McKee, A.C., Cairns, N.J., Dickson, D.W., et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathologica. 2016;131(1):75–86.
3. Bieniek, K.F., Cairns, N.J., Crary, J.F., et al. The second NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Journal of Neuropathology & Experimental Neurology. 2021;80(3):210–219.
4. Mez, J., Daneshvar, D.H., Kiernan, P.T., et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017;318(4):360–370.
5. Montenigro, P.H., Baugh, C.M., Daneshvar, D.H., et al. Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome. Alzheimer's Research & Therapy. 2014;6(5):68.
6. Cantu, R.C., Budson, A.E. Management of chronic traumatic encephalopathy. Expert Review of Neurotherapeutics. 2019;19(10):1015–1023.
7. Katz, D.I., Bernick, C., Dodick, D.W., et al. National Institute of Neurological Disorders and Stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology. 2021;96(18):848–863.
8. Dickstein, D.L., Pullman, M.Y., Fernandez, C., et al. Cerebral [18F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy. Translational Psychiatry. 2016;6(9):e900.
9. Arena, J.D., Stewart, W., Schneider, A.L.C., et al. Performance of traumatic encephalopathy syndrome criteria in identifying individuals with chronic traumatic encephalopathy. Nature Medicine. 2026;32:2037–2046.
10. Iverson, G.L., Gardner, A.J. Risk for misdiagnosing chronic traumatic encephalopathy in men with anger control problems. Frontiers in Neurology. 2020;11:739.
11. Iverson, G.L., Gardner, A.J. Risk of misdiagnosing chronic traumatic encephalopathy in men with depression. Journal of Neuropsychiatry and Clinical Neurosciences. 2020;32(2):139–146.
12. Iverson, G.L., Gardner, A.J. Symptoms of traumatic encephalopathy syndrome are common in the United States general population. Brain Communications. 2021;3(1):fcab001.
<